Nuoyi Mayer Completes Hundreds of Millions RMB Series B Financing Led by Suzhou High-Tech Financial Holding to Advance Innovation and Globalization of Tissue Engineering Scaffold Products

VCBeat learned第一时间 that recently, Neo Modulus (Suzhou) Medical Sci-Tech Co., Ltd. announced the completion of a billion-yuan B-round financing, led bySu High-Tech FinanceLed by [Investor Name], followed by Junmao Capital, CDH Investments, Huiding Investment, Yiling Capital, and Boya Gentian, among other investment institutions. This round of financing will mainly be used for clinical trials of multiple innovative medical device products in the field of tissue engineering, as well as the implementation of international strategies for multiple product pipelines.

Neo Modulus was founded in March 2017 as an innovative enterprise that researches and produces regenerative implant medical devices for "tissue repair and organ regeneration" in the human body. Over the past six years since its establishment, Neo Modulus has been committed to creating first-of-their-kind products and technologies in China while achieving international leadership. The company has engaged in deep collaboration with research institutions such as the University of Freiburg in Germany, gaining expertise in advanced raw material design and development as well as key process preparation technologies. This has enabled the localization of high-end core equipment production in China, forming independent intellectual property rights and breaking through foreign technological barriers.

Through the introduction of domestic and international technologies and independent innovation in high-end equipment, Neo Modulus' product line covers key technical routes in the field of tissue engineering such as electrospinning, 3D printing, and chemical synthesis. It encompasses a wide range of product forms including membranes, bone materials, gels, and agents, extending to multiple clinical departments such as dentistry, ophthalmology, otolaryngology, surgery, reproductive medicine, and sports medicine. Neo Modulus is one of the comprehensive solution providers in China with a complete range of offerings and advanced technology in the fields of regenerative medicine and tissue engineering.

Neo Modulus has successively been selected for the National Foreign Experts Project Plan, Jiangsu Province's Two-Creative Talents, Jiangsu Province's Top 100 Foreign Experts, Jiangsu Province's Key Research and Development Plan, and Shandong Province’s Top 100 Foreign Experts Team. It has won major awards in innovation and entrepreneurship competitions such as China Innovation and Entrepreneurship Competition, "Entrepreneurship in Jiangsu," and "Winning in Suzhou." The company has consistently ranked on unicorn evaluation lists including "China's Potential Unicorn Enterprises," "Jiangsu Province's Potential Unicorn Enterprises," "Southern Jiangsu National Independent Innovation Demonstration Zone’s Potential Unicorn Enterprises," and "Suzhou City’s Unicorn Cultivation Enterprises."

Neo Modulus has established three R&D and production bases in Suzhou, Weifang, and Taicang, a medical center in Beijing, and an overseas laboratory in Freiburg, Germany, forming a "3+1+1" R&D and innovation structure. Since its establishment, high-end medical device products such as the "gelatin-polycaprolactone layered gingival repair membrane" and "nasal cavity filling sponge" have successively been approved to enter the special review process for innovative medical devices.

Currently, Neo Modulus is developing articular cartilage regeneration products aimed at promoting genuine hyaline cartilage and subchondral bone regeneration without the use of cells, growth factors, or other drugs; as well as next-generation biodegradable vascular grafts designed for dialysis patients with chronic kidney disease, focusing on addressing the durability and sustainability of artificial vascular grafts.

In the future, Neo Modulus will always adhere to the "innovation + internationalization" of its tissue engineering scaffold product series, striving to achieve the long-term goal of "deciphering the regeneration code and safeguarding human health."

SU High-Tech FinanceNeo Modulus has comprehensive proprietary platform technology in the fields of tissue engineering and regenerative medicine. It has made significant progress in the research, development, and innovation of high-end medical device products such as gingival repair and cartilage regeneration, solving multiple "bottleneck" technical challenges. We believe that Neo Modulus will continue to "weave life and print the future" in its future development.

Prof. Dr. Thorsten Tobias Steinberg, Co-founder and Chief Scientist of Neo Modulus, Professor at the University of Freiburg, Germany, and Doctoral SupervisorNeo Modulus stated that, thanks to the support from investment institutions such as SND Finance, the injection of new funds will accelerate the implementation of Neo Modulus' innovation and internationalization strategies, promoting its core products to reach international first-class standards.